Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2009 Results

Tuesday, January 27, 2009 General News J E 4
GLENWOOD, Ill., Jan. 26 Landauer, Inc.(NYSE: LDR), will release financial results for the fiscal first quarter of2009 pre-market on Tuesday, February 3, 2009.

The company will host a conference call for investors on Tuesday, February3, 2009, at 2:00 p.m. Eastern Time. Investors may access the live call bydialing 800-240-2430 (within the United States and Canada), or 303-262-2053(international callers), or by visiting the "Investors" page on the company'swebsite at Please log on to the website at least15 minutes early to register, download and install any necessary audiosoftware.

Investors may access a replay of the call by dialing 800-405-2236 (withinthe United States and Canada), or 303-590-3000 (international callers),passcode 11125807#, which will be available through 12:00 a.m. on March 5,2009. The replay will also be available on Landauer's website for 90 daysfollowing the call.

About Landauer

Landauer is the leading provider of analytical services to determineoccupational and environmental radiation exposure. For more than 50 years,the Company has provided complete radiation dosimetry services to hospitals,medical and dental offices, universities, national laboratories, and otherindustries in which radiation poses a potential threat to employees.Landauer's services include the manufacture of various types of radiationdetection monitors, the distribution and collection of the monitors to andfrom clients, and the analysis and reporting of exposure findings.

For the latest news releases and other corporate documents on LandauerInc., visit

SOURCE Landauer, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Mardil Inc. Advances Its Novel Cardiac Device to F...
Nephros Common Stock Now Quoted in Pink Sheets